A tyrosine-to-threonine mutation converts cycloartenol synthase to an oxidosqualene cyclase that forms lanosterol as its major product [1]

Journal of the American Chemical Society

Volumn 122, Issue 28, 2000, Pages 6765-6766

  Herrera, Jennifer B R ^a   Wilson, William K ^a   Matsuda, Seiichi P T ^a  

^a RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LANOSTEROL SYNTHASE; SQUALENE DERIVATIVE;

CHEMICAL COMPOSITION; ENZYME ACTIVE SITE; ENZYME MODIFICATION; ENZYME STRUCTURE; LETTER; QUANTITATIVE DIAGNOSIS; STRUCTURE ANALYSIS;

EID: 0034686761     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja0013226     Document Type: Letter

References (26)

1. Matsuda, S. P. T. In Biochemical Principles and Mechanisms of Biosynthesis and Biodegradation of Polymers; Steinbüchel, A., Ed.; Wiley-VCH: Weinheim, 1998; pp 300-307.
2. Kushiro, T.; Shibuya, M.; Ebizuka, Y. Eur. J. Biochem. 1998, 256, 238-244.
3. Herrera, J. B. R.; Bartel, B.; Wilson, W. K.; Matsuda, S. P. T. Phytochemistry 1998, 49, 1905-1911.
4. Kushiro, T.; Shibuya, M.; Ebizuka, Y. J. Am. Chem. Soc. 1999, 121, 1208-1216.
5. Corey, E. J.; Matsuda, S. P. T.; Bartel, B. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 11628-11632.
6. Hart, E. A.; Hua, L.; Darr, L. B.; Wilson, W. K.; Pang, J.; Matsuda, S. P. T. J. Am. Chem. Soc. 1999, 121, 9887-9888.
7. Joubert, B. M.; Hua, L.; Matsuda, S. P. T. Org. Lett. 2000, 2, 339-341.
8. (a) Morita, M.; Shibuya, M.; Lee, M.-S.; Sankawa, U.; Ebizuka, Y. Biol. Pharm. Bull. 1997, 20, 770-775.
9. (b) Hayashi, H.; Hiraoka, N.; Ikeshiro, Y.; Yazaki, K.; Tanaka, S.; Kushiro, T.; Shibuya, M.; Ebizuka, Y. Plant Physiol. 1999, 121, 1384.
10. (c) Hayashi, H.; Hiraoka, N.; Ikeshiro, Y.; Kushiro, T.; Morita, M.; Shibuya, M.; Ebizuka, Y. Biol. Pharm. Bull. 2000, 23, 231-234.
11. Godzina, S. M.; Lovato, M. A.; Meyer, M. M.; Foster, K. A.; Wilson, W. K.; Gu, W.; de Hostos, E. L.; Matsuda, S. P. T. Lipids 2000, 36, 249-255.
12. Arabidopsis thaliana cycloartenol synthase numbering is used, with the corresponding conserved lanosterol synthase residue in parentheses.
13. Corey, E. J.; Matsuda, S. P. T.; Baker, C. H.; Ting, A. Y.; Cheng, H. Biochem. Biophys. Res. Commun. 1996, 219, 327-331.
14. The lanosterol synthase mutation in LHY4 ensures that any observed activity results from the recombinant gene. In addition, the squalene synthase mutation precludes in vivo triterpene biosynthesis, preventing the accumulation of compounds that would otherwise skew apparent product ratios by contributing to the isolated yields.
15. Pascal, R. A., Jr.; Farris, C. L.; Schroepfer, G. J., Jr. Anal. Biochem. 1980, 101, 15-22.
16. Emmons, G. T.; Wilson, W. K.; Schroepfer, G. J., Jr. Magn. Reson. Chem. 1989, 27, 1012-1024.
17. (a) Smith, A. G.; Goad, L. J. Biochem. J. 1975, 146, 25-33.
18. (b) Smith, A. G.; Goad, L. J. Biochem. J. 1975, 146, 35-40.
19. (c) Cordeiro, M. L.; Djerassi, C. J. Org. Chem. 1990, 55, 2806-2813.
20. Ochs, D.; Kaletta, C.; Entian, K.-D.; Beck-Sickinger, A.; Poralla, K. J. Bacteriol. 1992, 174, 298-302.
21. (a) Wendt, K. U.; Poralla, K.; Schulz, G. E. Science 1997, 277, 1811-1815.
22. (b) Wendt, K. U.; Lenhart, A., Schulz, G. E. J. Mol. Biol. 1999, 286, 175-187.
23. Dougherty, D. A. Science 1996, 271, 163-168.
24. Concerted reactions without discrete C-8 or C-9 cations or elimination from a C-8, C-9 bridged structure are also plausible.
25. Shibuya, M.; Zhang, H.; Endo, A.; Shishikura, K.; Kushiro, T.; Ebizuka, Y. Eur. J. Biochem. 1999, 266, 302-307.
26. Kushiro, T.; Shibuya, M.; Ebizuka, Y. In Towards Natural Medicine Research in the 21st Century, Excerpta Medica International Congress Series 1157; Ageta, H., Aimi, N., Ebizuka, Y., Fujita, T., Honda, G., Eds.; Elsevier Science: Amsterdam, 1998; pp 421-428.